NCT03455452View on ClinicalTrials.gov

Non-Interventional Study (NIS) of Nivolumab With or Without Ipilimumab in Participants With Advanced Kidney Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

January 21, 2018

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Renal Cell CarcinomaRenal Cell CancerAdenocarcinoma Of KidneyAdenocarcinoma, Renal CellKidney CancerCancer of the Kidney
Trial Locations (1)

75002

Local Institution - 0001, Paris

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY